[Refractory heart failure: it requires the use of polychemotherapy. What is the rationale?].
作者信息
Campa P P, Puddu P E, Schiariti M, Monti F, Dawodu A A, Gentile C, Lilla Della Monica P L, Vaccaro M, De Biase L
机构信息
II Cattedra di Cardiologia, Università degli Studi, La Sapienza, Roma.
出版信息
Cardiologia. 1995 Dec;40(12 Suppl 1):139-50.
PMID:8998706
Abstract
摘要
相似文献
1
[Refractory heart failure: it requires the use of polychemotherapy. What is the rationale?].
Cardiologia. 1995 Dec;40(12 Suppl 1):139-50.
2
[The differential therapy of chronic heart failure].
Dtsch Med Wochenschr. 1990 Aug 31;115(35):1319-24. doi: 10.1055/s-2008-1065161.
3
[How I treat... a patient with severe or aggravated cardiac insufficiency].
Rev Med Liege. 1995 May;50(5):197-8.
4
[Pharmacologic interactions with nitrates in patients with, or at risk of, cardiac decompensation].
G Ital Cardiol. 1996 Sep;26(9):1085-8.
5
[Therapy of dilated cardiomyopathy with digitalis, diuretics and vasodilators].
Herz. 1985 Jun;10(3):138-42.
6
[Therapy of heart failure. Digitalis, diuretic plus ACE inhibitor or more?].
Internist (Berl). 1995 Dec;36(12):1117-23.
7
Drugs for chronic heart failure.
Med Lett Drugs Ther. 1993 May 14;35(896):40-2.
8
[Chronic left heart ventricle failure and inotropic stimulation].
Tidsskr Nor Laegeforen. 1995 Jan 30;115(3):360-4.
9
[Treatment of dilated cardiomyopathies. Recent findings].
Ann Cardiol Angeiol (Paris). 1986 Jun;35(6):311-6.
10
[Exercise test in the evaluation of the efficacy of drug therapy].
Ital Heart J Suppl. 2000 Mar;1(3):393-9.
Zotero 插件